IL-27 can dampen the severity of the disease in EAE mouse models and in RRMS patients IL-27 and soluble IL-27Rα are elevated and could reduce the effect of IL-27 on immune cell function [67]. This evidence concerns the gene IL27RA and relapsing-remitting multiple sclerosis.